Australian owned & operatedAustralian flag
Card Payments AvailableVisaMastercardApple Pay
Home/Shop/CagriSema 10mg
CagriSema 10mg lyophilised research peptide blend vial – Solatide Biosciences

Images are for illustration purpose only

CagriSema 10mg

★★★★★
5 Reviews

CagriSema is a pre-blended lyophilised research material combining Cagrilintide (5mg) and Semaglutide (5mg).

Research Use Only: This product is strictly for laboratory research and is not intended for human or veterinary consumption, therapeutic use, diagnostic use, or clinical application.

Useful Resources: Concentration Calculator | CagriSema Research Overview | CagriSema vs Semaglutide | CagriSema vs Tirzepatide | CagriSema vs Retatrutide | COA & Lab Testing

Full Manufacturer QC Panel Passed

Each batch undergoes a full manufacturer QC panel prior to release.

Manufacturer QC confirms batch release against internal quality specifications.

Detailed manufacturer QC results are not publicly displayed.

Third-party testing in progress

Additional third-party testing is currently in progress for this batch.

Verified third-party results will be published here once available.

$149.95 AUD
Quantity
1

Product Overview

Understanding CagriSema 10mg

CagriSema 10mg is a pre-blended lyophilised research material combining Cagrilintide (5mg) and Semaglutide (5mg) in a single vial for in-vitro laboratory and analytical use. This dual-component blend enables simultaneous investigation of amylin receptor and GLP-1 receptor pathway interactions, receptor crosstalk mechanisms, and synergistic signalling in laboratory models. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation.

Research Applications

•Dual GLP-1 and Amylin Receptor Pathway Studies: Investigate simultaneous amylin and GLP-1 receptor activation and downstream pathway modulation in vitro.
•Receptor Crosstalk and Synergistic Signalling: Study CagriSema-mediated receptor pathway interactions and synergistic signalling consequences in experimental models.
•Comparative Single-Agent vs Combination Research: Compare CagriSema combination effects against individual Cagrilintide or Semaglutide in receptor binding assays.
•Metabolic Signalling Pathway Analysis: Examine combined amylin and incretin receptor metabolic signalling in experimental cell models.
This analytical standard is strictly for in-vitro laboratory research use only.

Technical Specifications

Technical Parameter
Laboratory Specification
Purity
≥99% based on available third-party documentation
Composition
5mg Cagrilintide + 5mg Semaglutide
Total Content
10mg per vial
CAS Number (Cagrilintide)
2413927-92-9
CAS Number (Semaglutide)
910463-68-2
Appearance
White Lyophilised Powder
Storage
Short term: 2–8°C. Long term: −20°C. Keep unopened material sealed, dry and protected from light.

Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.

Reviews

Customer Reviews

5.0
★★★★★
Based on 5 verified reviews
T
Torz
28/09/2026

Kind support

The person who replied was patient and didn't make me feel silly for asking. Really appreciated that.

C
Chris B
06/05/2026

Would buy again

Such a good price

C
Chris
19/03/2026

Can't find this stuff anywhere for this price, been a customer of Solatide and they have very fair priicng and great quality so was happy to see they stock this

A
Ash
29/12/2025

Trusted them

I was cautious because I had not paid by transfer before, but they handled it professionally.

A
Amelia
18/12/2025

Happy with price

Happy with the price. That was the main thing for me.

Cart

0

Your cart is currently empty.